Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03488914 · ClinicalTrials.gov registry record · NA
Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color
A NA study of Substance Use and Sexual Risk, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 2
- Study locations
NCT03488914: Completed NA study of Substance Use and Sexual Risk, sponsored by Hunter College of City University of New York.
NCT03488914 is a NA study of Substance Use and Sexual Risk that has completed, run by Hunter College of City University of New York. The registered enrollment target is 86 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03488914, a NA study of Substance Use and Sexual Risk, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.
Primary Outcome
The self-reported number of illicit drug use days (not including marijuana) in the past 90 days
Conditions Studied
Interventions
- BEHAVIORAL YMHP Intervention
- BEHAVIORAL Enhanced Treatment as Usual
Study Locations (2)
New York
- Bridging Access to Care - Brooklyn
- BOOM!Health - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2016-06-15 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
What the finished NCT03488914 record still lists
NCT03488914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which YMHP Intervention is the first listed.
NCT03488914 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03488914 about?
NCT03488914 is a clinical study titled "Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color". This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.
What is the current status of trial NCT03488914?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2016-06-15. Estimated completion is 2021-04-30.
What conditions does trial NCT03488914 study?
This clinical trial studies the following conditions: Substance Use, Sexual Risk.
What interventions are being tested in trial NCT03488914?
The interventions under investigation include: YMHP Intervention (BEHAVIORAL), Enhanced Treatment as Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT03488914?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03488914 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03488914's enrollment target sits among peer trials
86 65th of 88 higher than 23 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI